Aethlon Medical (AEMD) Change in Accured Expenses (2010 - 2026)
Aethlon Medical (AEMD) posted Change in Accured Expenses of $362450.0 for Q1 2026, up 186.7% on a QoQ basis from -$418055.0 in Q4 2025, and up 45.72% year-over-year from $248736.0 in Q1 2025.
Aethlon Medical (AEMD) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Aethlon Medical's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $362450.0 for Q1 2026.
- Quarterly Change in Accured Expenses rose 45.72% year-over-year to $362450.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$383384.0 (down 618.49% YoY) and the FY2026 annual result came in at -$383384.0, down 618.49% from the prior year.
- Change in Accured Expenses was $362450.0 for Q1 2026 at Aethlon Medical, up from -$418055.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $540780.0 in Q1 2022 and bottomed at -$418055.0 in Q4 2025.
- A 5-year average of $5058.1 and a median of -$25892.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses sank 1435.09% — and 2025, when it soared 1118.7%.
- Aethlon Medical's Change in Accured Expenses stood at $304572.0 in 2022, then sank by 108.5% to -$25892.0 in 2023, then sank by 1435.09% to -$397466.0 in 2024, then retreated by 5.18% to -$418055.0 in 2025, then jumped by 186.7% to $362450.0 in 2026.
- Business Quant data shows AEMD's Change in Accured Expenses at $362450.0 in Q1 2026, -$418055.0 in Q4 2025, and -$190287.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Aethlon Medical | 7,224.60 | 7,224.60 | - | 362,450.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,450.00 |
| Mar 31, 2026 | 362,450.00 |
| Dec 31, 2025 | -418,055.00 |
| Dec 31, 2025 | -418,055.00 |
| Sep 30, 2025 | -190,287.00 |
| Sep 30, 2025 | -190,287.00 |
| Jun 30, 2025 | -137,492.00 |
| Jun 30, 2025 | -137,492.00 |
| Mar 31, 2025 | 248,736.00 |
| Mar 31, 2025 | 248,736.00 |
| Dec 31, 2024 | -397,466.00 |
| Dec 31, 2024 | -397,466.00 |
| Sep 30, 2024 | -228,406.00 |
| Sep 30, 2024 | -228,406.00 |
| Jun 30, 2024 | 323,776.00 |
| Jun 30, 2024 | 323,776.00 |
| Mar 31, 2024 | 20,410.00 |
| Mar 31, 2024 | 20,410.00 |
| Dec 31, 2023 | -25,892.00 |
| Dec 31, 2023 | -25,892.00 |